Can we identify a post‐Serenoa syndrome (PSS)? A case series on sexual and psychiatric side effects of Serenoa repens
British Journal of Clinical Pharmacology · 2026
DOI: 10.1002/bcp.70442 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Filippo Firenzuoli und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, Section of Anaesthesiology, Intensive Care and Pain Medicine, University of Florence, Florence, Italy. Hauptthemen laut MEDLINE: 5-alpha Reductase Inhibitors, Plant Extracts, Serenoa, Sexual Dysfunction, Physiological. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Serenoa repens is widely used for benign prostatic hyperplasia and androgenetic alopecia due to its 5alpha‐reductase inhibitory activity. However, emerging reports describe sexual, psychiatric and somatic adverse effects resembling a post‐finasteride syndrome. Cases were identified from self‐reports submitted to an Italian online forum dedicated to post‐finasteride syndrome. All individuals underwent structured clinical evaluation at the CERFIT centre, including medical and psychiatric history, symptom assessment and available laboratory data. Reports were documented using the official Italian pharmacovigilance forms ( www.vigierbe.it ), and causality was independently assessed by two clinicians using the Naranjo Scale. Reported doses ranged from 120–900 mg/day, with adverse effects emerging within 1 month in 61% of cases. Symptoms were severe and persistent (mean duration 4.7 years), with complete remission in only three patients. According to the Naranjo Scale, causality was deemed ‘probable’ in 54% of reports; combined therapies (e.g., S. repens plus finasteride) were associated with increased severity and persistence. A possible post‐Serenoa syndrome marked by persistent sexual and neuropsychiatric symptoms may represent an underestimated issue. Misbelief in the absolute safety of S. repens likely hinders reporting. Given its widespread, unsupervised use, further pharmacovigilance and clinical studies are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Sciences, Section of Anaesthesiology, Intensive Care and Pain Medicine, University of Florence, Florence, Italy.
- CERFIT, Referring Centre for Phytotherapy, University Hospital of Careggi, Florence, Italy.
- Division of Psychiatry, Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
- Department of Mental Health, Azienda USL Toscana Centro, Florence, Italy.
- Unit of Urological Robotic Surgery and Renal Transplantation, Careggi Hospital, University of Florence, Florence, Italy.
- National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy.
ORCID-Profile: Filippo Firenzuoli, Ilaria Ippoliti, Valentina Maggini
Zitieren
APA
Firenzuoli, F., Firenzuoli, B., Mascherini, V., Firenzuoli, N., Menniti-Ippolito, F., Ippoliti, I., Maggini, V., Gallo, E., Cuomo, A., Fagiolini, A., Gensini, G. F., & Firenzuoli, F. (2026). Can we identify a post‐Serenoa syndrome (PSS)? A case series on sexual and psychiatric side effects of Serenoa repens. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70442
Vancouver
Firenzuoli F, Firenzuoli B, Mascherini V, Firenzuoli N, Menniti-Ippolito F, Ippoliti I, et al. Can we identify a post‐Serenoa syndrome (PSS)? A case series on sexual and psychiatric side effects of Serenoa repens. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70442
BibTeX
@article{Firenzuoli2026,
author = {Firenzuoli, Filippo and Firenzuoli, Bernardo and Mascherini, Vittorio and Firenzuoli, Niccolò and Menniti-Ippolito, Francesca and Ippoliti, Ilaria and Maggini, Valentina and Gallo, Eugenia and Cuomo, Alessandro and Fagiolini, Andrea and Gensini, Gian Franco and Firenzuoli, Fabio},
title = {Can we identify a post‐Serenoa syndrome (PSS)? A case series on sexual and psychiatric side effects of Serenoa repens},
journal = {British Journal of Clinical Pharmacology},
year = {2026},
doi = {10.1002/bcp.70442}
}
EUVIMED